David Scott Miller


AuthID: R-00K-250

Confirmed Publications: 293



91
TITLE: Locally Advanced Cervical Cancer: Outcomes with Variable Adherence to Treatment. Outcomes With Variable Adherence to Treatment
AUTHORS: Dustin B Manders; Abel Morón; Donald McIntire; David Scott Miller ; Debra L Richardson; Siobhan M Kehoe; Kevin V Albuquerque; Jayanthi S Lea;
PUBLISHED: 2018, SOURCE: American Journal of Clinical Oncology: Cancer Clinical Trials, VOLUME: 41, ISSUE: 5
INDEXED IN: Scopus CrossRef: 4
IN MY: ORCID
92
TITLE: Pre-operative core muscle index in combination with hypoalbuminemia is associated with poor prognosis in advanced ovarian cancer  Full Text
AUTHORS: Lesley B Conrad; Haitham Awdeh; Stefany Acosta Torres; Steven A Conrad; April A Bailey; David Scott Miller ; Jayanthi S Lea;
PUBLISHED: 2018, SOURCE: Journal of Surgical Oncology, VOLUME: 117, ISSUE: 5
INDEXED IN: Scopus CrossRef: 28
IN MY: ORCID
93
TITLE: Prognostic Significance of Nodal Location and Ratio in Stage IIIC Endometrial Carcinoma among a Multi-Institutional Academic Collaboration
AUTHORS: Jyoti Mayadev; Mohamed A Elshaikh; Alana Christie; Christa Nagel; Vanessa Kennedy; Nadia Khan; Jayanthi Lea; Ahmad Ghanem; David Scott Miller ; Xian Jin Xie; Michael Folkert; Kevin Albuquerque;
PUBLISHED: 2018, SOURCE: American Journal of Clinical Oncology: Cancer Clinical Trials, VOLUME: 41, ISSUE: 12
INDEXED IN: Scopus CrossRef: 6
IN MY: ORCID
94
TITLE: QUADRA: A phase 2, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) who have received ≥3 prior chemotherapy regimens.
AUTHORS: Kathleen N Moore; Angeles Alvarez Secord; Melissa Ann Geller; David Scott Miller ; Noelle Gillette Cloven; Gini F Fleming; Andrea Elisabeth Wahner Hendrickson; Masoud Azodi; Paul DiSilvestro; Amit M Oza; Mihaela C Cristea; Jonathan S Berek; John K Chan; Yong Li; Romnee Clark; Ursula A Matulonis; Bradley J Monk;
PUBLISHED: 2018, SOURCE: Journal of Clinical Oncology, VOLUME: 36, ISSUE: 15_suppl
INDEXED IN: CrossRef: 19
IN MY: ORCID
95
TITLE: QUADRA: A phase II, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) in 4th or later line of therapy: Results from the tBRCAmut subset
AUTHORS: K.N Moore; A.A Secord; Geller, M; David Scott Miller ; N.G Cloven; G.F Fleming; A.E Wahner Hendrickson; Azodi, M; DiSilvestro, P; Oza, A; Cristea, M; J.S Berek; J.K Chan; B.J Rimel; Li, Y; Luptakova, K; Clark, R; U.A Matulonis; B.J Monk;
PUBLISHED: 2018, SOURCE: Annals of Oncology, VOLUME: 29
INDEXED IN: CrossRef: 4
IN MY: ORCID
96
TITLE: Screening for Lynch syndrome in a medically underserved population  Full Text
AUTHORS: J.E Parker; K.Y Lin; David Scott Miller ; J.S Lea;
PUBLISHED: 2018, SOURCE: Gynecologic Oncology, VOLUME: 149
INDEXED IN: CrossRef
IN MY: ORCID
97
TITLE: The Significance of Para-Aortic Nodal Size and the Role of Adjuvant Systemic Chemotherapy in Cervical Cancer An Institutional Experience. An Institutional Experience
AUTHORS: Dustin B Manders; Travis T Sims; April Bailey; Lindsay Hwang; Debra L Richardson; David Scott Miller ; Siobhan M Kehoe; Kevin V Albuquerque; Jayanthi S Lea;
PUBLISHED: 2018, SOURCE: American Journal of Clinical Oncology: Cancer Clinical Trials, VOLUME: 41, ISSUE: 12
INDEXED IN: Scopus CrossRef: 14
IN MY: ORCID
98
TITLE: Third-line salvage chemotherapy for recurrent carcinoma of the cervix is associated with minimal response rate and high toxicity
AUTHORS: Dustin B Manders; Siobhan M Kehoe; David Scott Miller ; Jayanthi S Lea; Debra L Richardson;
PUBLISHED: 2018, SOURCE: American Journal of Clinical Oncology: Cancer Clinical Trials, VOLUME: 41, ISSUE: 8
INDEXED IN: Scopus CrossRef: 3
IN MY: ORCID
99
TITLE: Usage and survival implications of surgical staging of inguinal lymph nodes in intermediate- to high-risk, clinical localized penile cancer: A propensity-score matched analysis
AUTHORS: Solomon L Woldu; Bo Ci; Ryan C Hutchinson; Laura Maria Krabbe; Nirmish Singla; Niccolo M Passoni; Timothy N Clinton; Ganesh V Raj; David Scott Miller ; Arthur I Sagalowsky; Yair Lotan; Yang Xie; Vitaly Margulis; Aditya Bagrodia;
PUBLISHED: 2018, SOURCE: Urologic Oncology: Seminars and Original Investigations, VOLUME: 36, ISSUE: 4
INDEXED IN: Scopus CrossRef: 20
IN MY: ORCID
100
TITLE: ZoptEC: Phase III randomized controlled study comparing zoptarelin with doxorubicin as second line therapy for locally advanced, recurrent, or metastatic endometrial cancer (NCT01767155).
AUTHORS: David Scott Miller ; Giovanni Scambia; Igor Bondarenko; Anneke M Westermann; Ana Oaknin; Amit M Oza; Alla Sergeevua Lisyanskaya; Ignace Vergote; Robert Michael Wenham; Sarah Madhu Temkin; Hani Gabra;
PUBLISHED: 2018, SOURCE: Journal of Clinical Oncology, VOLUME: 36, ISSUE: 15_suppl
INDEXED IN: CrossRef: 23
IN MY: ORCID
Page 10 of 30. Total results: 293.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service